首页 > 最新文献

The Lancet Regional Health: Western Pacific最新文献

英文 中文
A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based study 澳大利亚脊髓性肌萎缩症临床和遗传情况的当代分析:基于登记册的研究
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-06 DOI: 10.1016/j.lanwpc.2024.101237

Background

New paradigms of diagnosis and treatment have changed the neurodegenerative trajectory for individuals with spinal muscular atrophy (SMA). Registries are a critical tool to provide real-world data on treatment patterns, their effects and health care provision within this evolving paradigm of care. This study aimed to evaluate the phenotypic and genotypic landscape, treatment patterns and health impact of SMA in Australia through the national registry.

Methods

This cross-sectional study investigated demographic, clinical and genetic information, sequelae of weakness, treatment patterns and patient-reported outcomes amongst individuals with SMA enrolled in the Australian Neuromuscular Disease Registry (ANMDR) from 1st January 2020 to 30th April 2023. Descriptive statistics were used for analysis and Chi-Squared or Fisher's exact tests for associations.

Findings

195 individuals with SMA enrolled into the ANMDR. 5/195 (2.6%) were deceased by censor date. Of (n = 190) individuals living with SMA, 104/190 (54.7%) were children. Minimum Australian prevalence was 0.73/100,000. SMN2 copies were inversely associated with phenotype in those with homozygous SMN1 deletions (p < 0.0001)). Treatment was utilised in 154/190 (81%) of the population, with 65/137 (47.6%) of individuals perceiving improvements with therapeutic intervention on Patient/Parent Global Impression of Improvement scale (p < 0.0001). Engagement with multidisciplinary care practitioners was significantly higher among children with SMA than adults (93% versus 12%, p < 0.0001).

Interpretation

Despite diagnostic and therapeutic advances, mortality and the multi-systemic health impact of SMA continue to be experienced within the Australian population. Healthcare provision must align with patient-centred outcomes, adapting to meeting their changing but ongoing care requirements. The study identified the considerable unmet need for multidisciplinary care, not only for adults with SMA but also for the emerging cohort of treated children, emphasising the imperative for comprehensive healthcare provision to address their evolving needs.

Funding

No funding was received for this study.
背景新的诊断和治疗模式改变了脊髓性肌萎缩症(SMA)患者的神经退行性病变轨迹。在这一不断发展的治疗模式中,登记是提供有关治疗模式、治疗效果和医疗服务的真实数据的重要工具。这项横断面研究调查了 2020 年 1 月 1 日至 2023 年 4 月 30 日期间在澳大利亚神经肌肉疾病登记处 (ANMDR) 登记的 SMA 患者的人口统计学、临床和遗传信息、虚弱后遗症、治疗模式和患者报告的结果。分析中使用了描述性统计,并对相关性进行了Chi-Squared或费雪精确检验。截至普查日期,5/195(2.6%)人已死亡。在(n = 190)SMA 患者中,104/190(54.7%)为儿童。澳大利亚的最低患病率为 0.73/100,000。SMN2拷贝与同型SMN1缺失者的表型成反比(p < 0.0001)。154/190(81%)的患者接受了治疗,其中65/137(47.6%)的患者在接受治疗干预后,患者/家长对病情改善的总体印象量表(p <0.0001)有所改善。尽管在诊断和治疗方面取得了进步,但澳大利亚人的死亡率和 SMA 对多系统健康的影响仍然存在。医疗保健服务必须符合以患者为中心的结果,适应不断变化但持续的护理要求。该研究发现,不仅成人 SMA 患者,而且新出现的接受治疗的儿童群体对多学科护理的需求也未得到满足,因此强调必须提供全面的医疗保健服务,以满足他们不断变化的需求。
{"title":"A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based study","authors":"","doi":"10.1016/j.lanwpc.2024.101237","DOIUrl":"10.1016/j.lanwpc.2024.101237","url":null,"abstract":"<div><h3>Background</h3><div>New paradigms of diagnosis and treatment have changed the neurodegenerative trajectory for individuals with spinal muscular atrophy (SMA). Registries are a critical tool to provide real-world data on treatment patterns, their effects and health care provision within this evolving paradigm of care. This study aimed to evaluate the phenotypic and genotypic landscape, treatment patterns and health impact of SMA in Australia through the national registry.</div></div><div><h3>Methods</h3><div>This cross-sectional study investigated demographic, clinical and genetic information, sequelae of weakness, treatment patterns and patient-reported outcomes amongst individuals with SMA enrolled in the Australian Neuromuscular Disease Registry (ANMDR) from 1st January 2020 to 30th April 2023. Descriptive statistics were used for analysis and Chi-Squared or Fisher's exact tests for associations.</div></div><div><h3>Findings</h3><div>195 individuals with SMA enrolled into the ANMDR. 5/195 (2.6%) were deceased by censor date. Of (n = 190) individuals living with SMA, 104/190 (54.7%) were children. Minimum Australian prevalence was 0.73/100,000. <em>SMN2</em> copies were inversely associated with phenotype in those with homozygous <em>SMN1</em> deletions (<em>p &lt; 0.0001</em>)). Treatment was utilised in 154/190 (81%) of the population, with 65/137 (47.6%) of individuals perceiving improvements with therapeutic intervention on Patient/Parent Global Impression of Improvement scale (<em>p &lt; 0.0001</em>). Engagement with multidisciplinary care practitioners was significantly higher among children with SMA than adults (93% versus 12%, <em>p &lt; 0.0001</em>).</div></div><div><h3>Interpretation</h3><div>Despite diagnostic and therapeutic advances, mortality and the multi-systemic health impact of SMA continue to be experienced within the Australian population. Healthcare provision must align with patient-centred outcomes, adapting to meeting their changing but ongoing care requirements. The study identified the considerable unmet need for multidisciplinary care, not only for adults with SMA but also for the emerging cohort of treated children, emphasising the imperative for comprehensive healthcare provision to address their evolving needs.</div></div><div><h3>Funding</h3><div>No funding was received for this study.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142593205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A complex intervention to reduce antibiotic prescribing in rural China: a cluster randomised controlled trial 减少中国农村地区抗生素处方的复杂干预:分组随机对照试验
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-06 DOI: 10.1016/j.lanwpc.2024.101236

Background

Excessive use of antibiotics is a widespread problem. We aim to evaluate the efficacy of a multifaceted intervention for reducing antibiotic use in patients with respiratory tract infections (RTIs).

Methods

In this two-arm cluster randomized controlled trial, we enrolled patients aged 18+ with symptomatic RTIs at 40 township health centers (THCs) selected from 10 counties in Anhui, China. The THCs were randomized using an online tool (‘Sealed Envelope’) to intervention or usual care (1:1 ratio), stratified by baseline antibiotic prescribing and with random block sizes (4 or 6). The intervention had five components: a half-day clinician training, a WeChat-based peer support group, a decision aid, a poster commitment letter and a patient leaflet. The primary outcome was whether antibiotics were prescribed at the index consultation. Secondary measures included defined daily dose (DDD), illness recovery rate, re-visits to other care-givers or retail pharmacies and incremental cost-effectiveness ratio (ICER). These measures were analyzed using generalized linear mixed modeling controlling for clustering. The study was registered as ISRCTN30652037.

Findings

Between December 2021 and September 2022, 1053 patients were recruited (intervention, 21 THCs, n = 552; control, 19 THCs, n = 501), using consecutive sampling. Antibiotic prescribing rate was 55.25% and 66.67% in the intervention and control arms (Odds ratio 0.52, 95% confidence interval [CI]: 0.27, 0.98; p = 0.044). The intervention group also had lower, significant or non-significant, differences for other markers of antibiotic use: DDD (1.57 vs 2.75); prescriptions of two or more types of antibiotics (9.78% vs 11.58%); obtaining antibiotics from retail pharmacies (3.68% vs 5.78) or from other clinics (2.70% vs 4.05%). The intervention resulted in a cost reduction of 9.265 RMB (1.471 USD) per consultation episode and an ICER of −7769.98 RMB or −1233.33 USD/QALYs. The intervention did not encounter any major adverse event.

Interpretation

The intervention package was effective and cost-effective in reducing antibiotics prescribing without adverse effects.

Funding

The trial was supported by National Natural Science Foundation of China (No. 81861138049) and United Kingdom Research Innovation (No. MR/S013717/1).
背景过度使用抗生素是一个普遍存在的问题。方法 在这项双臂分组随机对照试验中,我们从中国安徽省 10 个县的 40 个乡镇卫生院(THC)中招募了 18 岁以上有症状的 RTI 患者。乡镇卫生院通过在线工具("密封信封")随机分配干预或常规护理(1:1 比例),按抗生素处方基线进行分层,并随机分配区块大小(4 或 6)。干预措施包括五个部分:为期半天的临床医生培训、基于微信的同伴支持小组、决策辅助工具、海报承诺函和患者宣传单。主要结果是在就诊时是否开具抗生素处方。次要指标包括定义的每日剂量(DDD)、疾病痊愈率、再次就诊于其他护理人员或零售药店的次数以及增量成本效益比(ICER)。采用广义线性混合模型对这些指标进行了分析,并对聚类进行了控制。研究结果在2021年12月至2022年9月期间,采用连续抽样的方法招募了1053名患者(干预组,21个THC,n = 552;对照组,19个THC,n = 501)。干预组和对照组的抗生素处方率分别为 55.25% 和 66.67%(比值比 0.52,95% 置信区间 [CI]:0.27,0.98;P = 0.044)。干预组在其他抗生素使用指标上的差异也较小,有显著性或无显著性差异:DDD(1.57 vs 2.75);两种或两种以上抗生素处方(9.78% vs 11.58%);从零售药店(3.68% vs 5.78)或其他诊所(2.70% vs 4.05%)获得抗生素。干预后,每次就诊的成本降低了 9.265 元人民币(1.471 美元),ICER 为-7769.98 元人民币或-1233.33 美元/QALYs。该干预方案对减少抗生素处方有效且具有成本效益,无不良反应。
{"title":"A complex intervention to reduce antibiotic prescribing in rural China: a cluster randomised controlled trial","authors":"","doi":"10.1016/j.lanwpc.2024.101236","DOIUrl":"10.1016/j.lanwpc.2024.101236","url":null,"abstract":"<div><h3>Background</h3><div>Excessive use of antibiotics is a widespread problem. We aim to evaluate the efficacy of a multifaceted intervention for reducing antibiotic use in patients with respiratory tract infections (RTIs).</div></div><div><h3>Methods</h3><div>In this two-arm cluster randomized controlled trial, we enrolled patients aged 18+ with symptomatic RTIs at 40 township health centers (THCs) selected from 10 counties in Anhui, China. The THCs were randomized using an online tool (‘Sealed Envelope’) to intervention or usual care (1:1 ratio), stratified by baseline antibiotic prescribing and with random block sizes (4 or 6). The intervention had five components: a half-day clinician training, a WeChat-based peer support group, a decision aid, a poster commitment letter and a patient leaflet. The primary outcome was whether antibiotics were prescribed at the index consultation. Secondary measures included defined daily dose (DDD), illness recovery rate, re-visits to other care-givers or retail pharmacies and incremental cost-effectiveness ratio (ICER). These measures were analyzed using generalized linear mixed modeling controlling for clustering. The study was registered as ISRCTN30652037.</div></div><div><h3>Findings</h3><div>Between December 2021 and September 2022, 1053 patients were recruited (intervention, 21 THCs, n = 552; control, 19 THCs, n = 501), using consecutive sampling. Antibiotic prescribing rate was 55.25% and 66.67% in the intervention and control arms (Odds ratio 0.52, 95% confidence interval [CI]: 0.27, 0.98; p = 0.044). The intervention group also had lower, significant or non-significant, differences for other markers of antibiotic use: DDD (1.57 vs 2.75); prescriptions of two or more types of antibiotics (9.78% vs 11.58%); obtaining antibiotics from retail pharmacies (3.68% vs 5.78) or from other clinics (2.70% vs 4.05%). The intervention resulted in a cost reduction of 9.265 RMB (1.471 USD) per consultation episode and an ICER of −7769.98 RMB or −1233.33 USD/QALYs. The intervention did not encounter any major adverse event.</div></div><div><h3>Interpretation</h3><div>The intervention package was effective and cost-effective in reducing antibiotics prescribing without adverse effects.</div></div><div><h3>Funding</h3><div>The trial was supported by <span>National Natural Science Foundation of China</span> (No. <span><span>81861138049</span></span>) and <span>United Kingdom Research Innovation</span> (No. <span><span>MR/S013717/1</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142593206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes 使用抗生素的时间对儿科发热性中性粒细胞减少症临床结果的影响:1685 例病例的目标试验模拟
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-02 DOI: 10.1016/j.lanwpc.2024.101226

Background

Prompt antibiotic administration for febrile neutropenia (FN) is standard of care, and targets of time to antibiotics (TTA) <60 min are common. We sought to determine the effect of TTA ≥60 versus <60 min on adverse outcomes (intensive care unit (ICU) admission or death) in children with cancer and FN. Effect modification by a decision rule that predicts infection (AUS-rule) and bacteraemia were also investigated.

Methods

The prospective, multi-centre (n = 8), Australian PICNICC study dataset was analysed. To control for confounding, we used outcome regression adjusted for propensity score modelled as restricted cubic spline with two degrees of freedom. The propensity score was estimated from a logistic regression model for the exposure on the confounders, identified a priori (age, sex, severely unwell, disease, chemotherapy intensity and site). TTA was defined as time from from emergency triage to first antibiotic dose.

Findings

1685 FN episodes in 976 patients were included. Median TTA was 53 min (IQR 37–77 min, 1542 (92%) <120 min). An adverse outcome occurred in 43 (2.6%) episodes (39 ICU; 5 deaths). The confounder-adjusted point estimate suggested a lower risk for adverse outcome associated with TTA ≥60 min (RR 0.62, 95% CI 0.32–1.21), but the wide 95% CI precluded definitive judgement about strength and direction of the effect (unadjusted RR 0.52; 95% CI 0.26, 1.05). Similarly, although the point estimates were suggestive of a null association or reduced risk for adverse outcome associated with TTA ≥60 min for all comparisons across bacteraemia or AUS-rule strata, the 95% CIs were imprecise.

Interpretation

For children with FN, there was no definite evidence that TTA ≥60 min from hospital triage (but within 2 h), increased risk of adverse outcome or prolonged hospital admission. This study has important implications for FN TTA mandates, suggesting a more nuanced approach is required.

Funding

National Health and Medical Research Council and Medical Research Future Fund.
背景发热性中性粒细胞减少症(FN)的及时抗生素应用是标准护理,抗生素应用时间(TTA)为 60 分钟的目标很常见。我们试图确定TTA≥60分钟与<60分钟对癌症和FN患儿不良结局(入住重症监护室或死亡)的影响。方法分析了澳大利亚 PICNICC 研究的前瞻性多中心(n = 8)数据集。为控制混杂因素,我们使用了根据倾向得分调整的结果回归,以两个自由度的受限立方样条为模型。倾向得分是根据事先确定的混杂因素(年龄、性别、严重不适、疾病、化疗强度和部位)暴露的逻辑回归模型估算得出的。TTA定义为从急诊分诊到首次服用抗生素的时间。中位 TTA 为 53 分钟(IQR 为 37-77 分钟,1542 (92%) <120 分钟)。43例(2.6%)发生不良后果(39例重症监护室;5例死亡)。混杂因素调整后的点估计值表明,TTA ≥60 分钟的不良结局风险较低(RR 0.62,95% CI 0.32-1.21),但 95% CI 较宽,无法明确判断影响的强度和方向(未调整 RR 0.52;95% CI 0.26,1.05)。同样,尽管在菌血症或 AUS 规则分层的所有比较中,点估计值均提示与 TTA ≥60 分钟相关的无效关联或不良结局风险降低,但 95% CI 不精确。这项研究对FN TTA规定具有重要意义,表明需要采取更细致的方法。
{"title":"Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes","authors":"","doi":"10.1016/j.lanwpc.2024.101226","DOIUrl":"10.1016/j.lanwpc.2024.101226","url":null,"abstract":"<div><h3>Background</h3><div>Prompt antibiotic administration for febrile neutropenia (FN) is standard of care, and targets of time to antibiotics (TTA) &lt;60 min are common. We sought to determine the effect of TTA ≥60 versus &lt;60 min on adverse outcomes (intensive care unit (ICU) admission or death) in children with cancer and FN. Effect modification by a decision rule that predicts infection (AUS-rule) and bacteraemia were also investigated.</div></div><div><h3>Methods</h3><div>The prospective, multi-centre (n = 8), Australian PICNICC study dataset was analysed. To control for confounding, we used outcome regression adjusted for propensity score modelled as restricted cubic spline with two degrees of freedom. The propensity score was estimated from a logistic regression model for the exposure on the confounders, identified <em>a priori</em> (age, sex, severely unwell, disease, chemotherapy intensity and site). TTA was defined as time from from emergency triage to first antibiotic dose.</div></div><div><h3>Findings</h3><div>1685 FN episodes in 976 patients were included. Median TTA was 53 min (IQR 37–77 min, 1542 (92%) &lt;120 min). An adverse outcome occurred in 43 (2.6%) episodes (39 ICU; 5 deaths). The confounder-adjusted point estimate suggested a lower risk for adverse outcome associated with TTA ≥60 min (RR 0.62, 95% CI 0.32–1.21), but the wide 95% CI precluded definitive judgement about strength and direction of the effect (unadjusted RR 0.52; 95% CI 0.26, 1.05). Similarly, although the point estimates were suggestive of a null association or reduced risk for adverse outcome associated with TTA ≥60 min for all comparisons across bacteraemia or AUS-rule strata, the 95% CIs were imprecise.</div></div><div><h3>Interpretation</h3><div>For children with FN, there was no definite evidence that TTA ≥60 min from hospital triage (but within 2 h), increased risk of adverse outcome or prolonged hospital admission. This study has important implications for FN TTA mandates, suggesting a more nuanced approach is required.</div></div><div><h3>Funding</h3><div><span>National Health and Medical Research Council</span> and <span>Medical Research Future Fund</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142571438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why I decide to leave South Korea healthcare system 我为何决定离开韩国医疗系统
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-11-01 DOI: 10.1016/j.lanwpc.2024.101232
{"title":"Why I decide to leave South Korea healthcare system","authors":"","doi":"10.1016/j.lanwpc.2024.101232","DOIUrl":"10.1016/j.lanwpc.2024.101232","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142554270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards an agenda of action and research for making health systems responsive to the needs of people with disabilities 制定行动和研究议程,使卫生系统满足残疾人的需求
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-24 DOI: 10.1016/j.lanwpc.2024.101225
Ensuring health systems responsiveness is crucial for health equity and outcomes of all individuals, particularly disadvantaged groups such as people with disabilities. However, attention to and discussions on health system responsiveness for people with disabilities remains lacking. This viewpoint highlights the pervasive issues within health systems rooted in ableism and proposes an agenda to tackle ableism, aiming to make health systems responsive to the needs of people with disabilities. Their needs are complex and diverse, varying with the disability, its severity, progression, and intersection with other factors. Ableism creates significant obstacles to identifying and addressing their needs and expectations, damages provider–patient interactions, poses multiple challenges in healthcare, and impacts the overall responsiveness of the health system to the populations it is meant to serve. The proposed agenda outlines areas for action and research across six building blocks of health systems as a way forward to enhance the health system's responsiveness to the needs of people with disabilities.
确保卫生系统的响应能力对于所有人,尤其是残疾人等弱势群体的健康公平和成果至关重要。然而,人们对卫生系统响应残疾人需求的关注和讨论仍然不足。这一观点强调了卫生系统中根植于残障主义的普遍问题,并提出了解决残障主义的议程,旨在使卫生系统对残障人士的需求做出回应。他们的需求复杂多样,因残疾、残疾的严重程度、残疾的发展以及与其他因素的交叉而异。残疾歧视给确定和满足他们的需求和期望造成了巨大障碍,损害了医疗服务提供者与患者之间的互动,给医疗保健带来了多重挑战,并影响了医疗系统对其服务人群的整体响应能力。拟议议程概述了医疗系统六个组成部分的行动和研究领域,以此作为提高医疗系统对残疾人需求的响应能力的前进方向。
{"title":"Towards an agenda of action and research for making health systems responsive to the needs of people with disabilities","authors":"","doi":"10.1016/j.lanwpc.2024.101225","DOIUrl":"10.1016/j.lanwpc.2024.101225","url":null,"abstract":"<div><div>Ensuring health systems responsiveness is crucial for health equity and outcomes of all individuals, particularly disadvantaged groups such as people with disabilities. However, attention to and discussions on health system responsiveness for people with disabilities remains lacking. This viewpoint highlights the pervasive issues within health systems rooted in ableism and proposes an agenda to tackle ableism, aiming to make health systems responsive to the needs of people with disabilities. Their needs are complex and diverse, varying with the disability, its severity, progression, and intersection with other factors. Ableism creates significant obstacles to identifying and addressing their needs and expectations, damages provider–patient interactions, poses multiple challenges in healthcare, and impacts the overall responsiveness of the health system to the populations it is meant to serve. The proposed agenda outlines areas for action and research across six building blocks of health systems as a way forward to enhance the health system's responsiveness to the needs of people with disabilities.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human carcinogen, leisure food, or local specialty: navigating areca nut regulation in China 人类致癌物、休闲食品还是地方特产:中国的马兜铃果监管之路
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-23 DOI: 10.1016/j.lanwpc.2024.101230
{"title":"Human carcinogen, leisure food, or local specialty: navigating areca nut regulation in China","authors":"","doi":"10.1016/j.lanwpc.2024.101230","DOIUrl":"10.1016/j.lanwpc.2024.101230","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142534970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
China's health national adaptation plan for climate change: action framework 2024–2030 中国健康国家适应气候变化规划:2024-2030 年行动框架
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-22 DOI: 10.1016/j.lanwpc.2024.101227
{"title":"China's health national adaptation plan for climate change: action framework 2024–2030","authors":"","doi":"10.1016/j.lanwpc.2024.101227","DOIUrl":"10.1016/j.lanwpc.2024.101227","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142534969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating the incidence of dementia in New Zealand: a cohort study applying capture-recapture modelling to routinely collected linked health datasets 估算新西兰痴呆症发病率:将捕获-再捕获模型应用于常规收集的关联健康数据集的队列研究
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-21 DOI: 10.1016/j.lanwpc.2024.101216

Background

Issues of under-diagnosis and under-coding of dementia in routinely collected health data limit their utility for estimating dementia prevalence and incidence in Aotearoa New Zealand (NZ). Capture-recapture techniques can be used to estimate the number of dementia cases missing from health datasets by modelling the relationships and interactions between linked data sources. The aim of this study was to apply this technique to routinely collected and linked health datasets and more accurately estimate the incidence of dementia in NZ.

Methods

All incident cases of dementia in the NZ 60+ population were identified in three linked national health data sets—interRAI, Public hospital discharges, and Pharmacy. Capture-recapture analysis fitted eight loglinear models to the data, with the best fitting model used to estimate the number of cases missing from all three datasets, and thereby estimate the ‘true’ incidence of dementia. Incidence rates were calculated by 5-year age bands, sex and ethnicity.

Findings

Modelled estimates indicate 36% of incident cases are not present in any of the datasets. Modelled incidence rates in the 60+ age group were 19.2 (95% CI 17.3–22.0)/1000py, with an incident rate ratio of 1.9 (95% CI 1.9–2.0) per 5-year age band. There was no difference in incidence rates between males and females. Incidence rates in Asian (p < 0.001) but not Māori (p = 0.974) or Pacific peoples (p = 0.110) were significantly lower compared to Europeans, even after inclusion of missing cases.

Interpretation

This is the first study to provide estimates of age 60+ dementia incidence in NZ and for the four main ethnic groups and suggests over a third of incident dementia cases are undiagnosed. This highlights the need for better access to dementia assessment and diagnosis so that appropriate supports and interventions can be put in place to improve outcomes for people living with dementia and their families.

Funding

Nil.
背景在常规收集的健康数据中,痴呆症诊断不足和编码不足的问题限制了这些数据在估算新西兰奥特亚罗瓦(Aotearoa New Zealand,NZ)痴呆症患病率和发病率方面的实用性。捕获-再捕获技术可以通过模拟关联数据源之间的关系和相互作用来估算健康数据集中缺失的痴呆症病例数。本研究的目的是将这一技术应用于常规收集和关联的健康数据集,并更准确地估算出新西兰的痴呆症发病率。方法从三个关联的国家健康数据集--国际痴呆症研究指数(interRAI)、公立医院出院数据和药房数据中识别出新西兰60岁以上人口中的所有痴呆症病例。捕获-再捕获分析将八个对数线性模型拟合到数据中,用拟合效果最好的模型来估计所有三个数据集中缺失的病例数,从而估计痴呆症的 "真实 "发病率。根据 5 年年龄段、性别和种族计算发病率。60 岁以上年龄组的模型发病率为 19.2(95% CI 17.3-22.0)/1000py,每个 5 年年龄段的发病率比为 1.9(95% CI 1.9-2.0)。男性和女性的发病率没有差异。与欧洲人相比,亚裔(p < 0.001)的发病率明显较低,但毛利人(p = 0.974)和太平洋岛屿族裔(p = 0.110)的发病率却不低,即使在纳入缺失病例后也是如此。这突显出需要更好地进行痴呆症评估和诊断,以便提供适当的支持和干预措施,改善痴呆症患者及其家人的生活质量。
{"title":"Estimating the incidence of dementia in New Zealand: a cohort study applying capture-recapture modelling to routinely collected linked health datasets","authors":"","doi":"10.1016/j.lanwpc.2024.101216","DOIUrl":"10.1016/j.lanwpc.2024.101216","url":null,"abstract":"<div><h3>Background</h3><div>Issues of under-diagnosis and under-coding of dementia in routinely collected health data limit their utility for estimating dementia prevalence and incidence in Aotearoa New Zealand (NZ). Capture-recapture techniques can be used to estimate the number of dementia cases missing from health datasets by modelling the relationships and interactions between linked data sources. The aim of this study was to apply this technique to routinely collected and linked health datasets and more accurately estimate the incidence of dementia in NZ.</div></div><div><h3>Methods</h3><div>All incident cases of dementia in the NZ 60+ population were identified in three linked national health data sets—interRAI, Public hospital discharges, and Pharmacy. Capture-recapture analysis fitted eight loglinear models to the data, with the best fitting model used to estimate the number of cases missing from all three datasets, and thereby estimate the ‘true’ incidence of dementia. Incidence rates were calculated by 5-year age bands, sex and ethnicity.</div></div><div><h3>Findings</h3><div>Modelled estimates indicate 36% of incident cases are not present in any of the datasets. Modelled incidence rates in the 60+ age group were 19.2 (95% CI 17.3–22.0)/1000py, with an incident rate ratio of 1.9 (95% CI 1.9–2.0) per 5-year age band. There was no difference in incidence rates between males and females. Incidence rates in Asian (p &lt; 0.001) but not Māori (p = 0.974) or Pacific peoples (p = 0.110) were significantly lower compared to Europeans, even after inclusion of missing cases.</div></div><div><h3>Interpretation</h3><div>This is the first study to provide estimates of age 60+ dementia incidence in NZ and for the four main ethnic groups and suggests over a third of incident dementia cases are undiagnosed. This highlights the need for better access to dementia assessment and diagnosis so that appropriate supports and interventions can be put in place to improve outcomes for people living with dementia and their families.</div></div><div><h3>Funding</h3><div>Nil.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rohingya refugee health and well-being in Malaysia: a call for research and action 马来西亚罗辛亚难民的健康和福祉:呼吁开展研究和行动
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-21 DOI: 10.1016/j.lanwpc.2024.101229
{"title":"Rohingya refugee health and well-being in Malaysia: a call for research and action","authors":"","doi":"10.1016/j.lanwpc.2024.101229","DOIUrl":"10.1016/j.lanwpc.2024.101229","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142534968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long Covid is a significant health crisis in China too 长颈鹿也是中国的一个重大健康危机
IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-14 DOI: 10.1016/j.lanwpc.2024.101223
{"title":"Long Covid is a significant health crisis in China too","authors":"","doi":"10.1016/j.lanwpc.2024.101223","DOIUrl":"10.1016/j.lanwpc.2024.101223","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142433284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Regional Health: Western Pacific
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1